BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, Donnelly CA, Chadeau-Hyam M, Elliott P. Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England. Nat Commun 2022;13:6856. [PMID: 36369151 DOI: 10.1038/s41467-022-34244-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Ellington S, Jatlaoui TC. COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy. Lancet 2023;401:412-3. [PMID: 36669521 DOI: 10.1016/S0140-6736(22)02613-7] [Reference Citation Analysis]
2 Gui H, Zhang Z, Chen B, Chen Y, Wang Y, Long Z, Zhu C, Wang Y, Cao Z, Xie Q. Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study. Infect Dis Poverty 2023;12:7. [PMID: 36750862 DOI: 10.1186/s40249-023-01057-4] [Reference Citation Analysis]
3 Pilotto A, Custodero C, Palmer K, Sanchez-Garcia EM, Topinkova E, Polidori MC; Members of the Special Interest Group on Comprehensive Geriatric Assessment of the EuGMS (European Geriatric Medicine Society). A multidimensional approach to older patients during COVID-19 pandemic: a position paper of the Special Interest Group on Comprehensive Geriatric Assessment of the European Geriatric Medicine Society (EuGMS). Eur Geriatr Med 2023;14:33-41. [PMID: 36656486 DOI: 10.1007/s41999-022-00740-3] [Reference Citation Analysis]
4 Weng C, Xie R, Han G, Yuan Y, Li S, Wang C, Wang X, Jiang W, Jiang L. Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients. Infect Dis Ther 2023;12:649-62. [PMID: 36696068 DOI: 10.1007/s40121-023-00760-x] [Reference Citation Analysis]
5 von Bartheld CS, Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis. Cells 2023;12. [PMID: 36766771 DOI: 10.3390/cells12030430] [Reference Citation Analysis]
6 Brechbühl J, Ferreira F, Lopes AC, Corset E, Gilliand N, Broillet MC. Ocular Symptoms Associated with COVID-19 Are Correlated with the Expression Profile of Mouse SARS-CoV-2 Binding Sites. Viruses 2023;15. [PMID: 36851565 DOI: 10.3390/v15020354] [Reference Citation Analysis]
7 von Bartheld CS, Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-analysis. medRxiv 2023:2022. [PMID: 36561176 DOI: 10.1101/2022.12.16.22283582] [Reference Citation Analysis]
8 Williams EC, Kizhner A, Stark VS, Nawab A, Muniz DD, Echeverri Tribin F, Carreño JM, Bielak D, Singh G, Hoffer ME, Krammer F, Pallikkuth S, Pahwa S. Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach. Front Immunol 2023;14:971277. [PMID: 36845120 DOI: 10.3389/fimmu.2023.971277] [Reference Citation Analysis]
9 Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci 2023;46:75-90. [PMID: 36470705 DOI: 10.1016/j.tins.2022.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Liu Y. Attenuation and Degeneration of SARS-CoV-2 Despite Adaptive Evolution. Cureus 2023;15:e33316. [PMID: 36741655 DOI: 10.7759/cureus.33316] [Reference Citation Analysis]
11 Geismar C, Nguyen V, Fragaszy E, Shrotri M, Navaratnam A, Beale S, Byrne T, Fong WL, Yavlinsky A, Kovar J, Hoskins S, Braithwaite I, Aldridge R, Hayward A. Symptom profiles of community cases infected by Influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern.. [DOI: 10.21203/rs.3.rs-2402048/v1] [Reference Citation Analysis]
12 Mahase E. Covid-19: Is the UK still tracking the virus-and other questions answered. BMJ 2022;379:o2802. [PMID: 36400434 DOI: 10.1136/bmj.o2802] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]